Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Baxter Healthcare Corporation recalls CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations
Products
  • CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection
Where it was sold

US Nationwide; Puerto Rico; and Chile.

Nationwide

Units affected
N/A
About this recall
CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.